Pro Tour Khans of Tarkir is finally over and it was a real roller coaster for prices on MTGO. Sylvain gives us his perspective on his Standard positions going forward.

After a few weeks of playing with the new cards, Mike Lanigan believes a few gems are still flying under the radar. He reveals what they are and provides some thoughts on the metagame.

With less than half of Khans of Tarkir spoiled, the future of Standard is starting to shape up and the key players have potentially already made their appearance. This week Ryan continues to flesh out the format and identifies currently legal cards you should have in your collection.

Be prepared and get an edge on the opposition by reading Adam’s comprehensive Legacy metagame report! Find a thorough metagame analysis and updated decklists for all major archetypes within.

With the upcoming release of Khans of Tarkir, Standard will lose the bulk of its current card pool. Adam outlines which strategies are expected to stick around, what cards may see a rise in popular, and how you can prepare and profit from the rotation.

Mike Lanigan surveys the new decks to come from the Pro Tour, as well as the price changes in key cards as we near rotation.

For speculators, the new core set release is often a sign of good opportunity. Sylvain reviews what he thinks might be worth picking up in Theros block, Modern and Vintage during the upcoming M15 release events.

Alexander Carl takes on the volatile Vintage Masters market. Where is the value? When should you buy Power? And what other opportunities are presenting themselves?

Mike Lanigan is equipped with a brand new Standard brew, G/W Constellation. He shares his thought process building it and the final result.

Taking a break from his portfolio management series, Sylvain reflects on the success of his block speculation surrounding the recent Pro Tour Journey Into Nyx. How did the PT affect the online market?

Mike Lanigan reviews Journey Into Nyx with his pick for the top ten cards most likely to impact Standard.

Speculators spend lots of time discussing buys, but what you don’t buy is just as crucial. David Schumann covers some cards that constitute bad investments right now.